Export products are one of the possible routes for the transboundary movement of chemical substances from Japan but are not included in the scope of the Pollutant Release and Transfer Register (PRTR) system in Japan. Scholars performed stock flow and exposure analyses and evaluated the substitution of chemicals with safer substances. However, all these works were conducted in Japan, and no quantitative study has considered the risks derived from chemicals in export products from the country. To fill such gap, this study quantitatively assessed the human health risk derived from the chemical substances contained in export products from Japan to the importing country and to verify the effectiveness of risk reduction measures, including substance substitution. Target countries were selected by characterizing Japan’s export partner countries. Human health risks were then estimated using Trade Statistics of Japan, cumulative Weibull distribution function, emission factors, and the USE tox model. The main finding was that the greatest risk reduction was achieved when substance substitution was conducted, and the importation of used products containing controlled substances was regulated in the importing country.

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Assessment of the Human Health Risk Derived from Chemicals in Export Products from Japan

  • Ryoma Kobayashi,
  • Lisa Ito,
  • Akihiro Tokai

摘要

Export products are one of the possible routes for the transboundary movement of chemical substances from Japan but are not included in the scope of the Pollutant Release and Transfer Register (PRTR) system in Japan. Scholars performed stock flow and exposure analyses and evaluated the substitution of chemicals with safer substances. However, all these works were conducted in Japan, and no quantitative study has considered the risks derived from chemicals in export products from the country. To fill such gap, this study quantitatively assessed the human health risk derived from the chemical substances contained in export products from Japan to the importing country and to verify the effectiveness of risk reduction measures, including substance substitution. Target countries were selected by characterizing Japan’s export partner countries. Human health risks were then estimated using Trade Statistics of Japan, cumulative Weibull distribution function, emission factors, and the USE tox model. The main finding was that the greatest risk reduction was achieved when substance substitution was conducted, and the importation of used products containing controlled substances was regulated in the importing country.